Originally published by our sister publication Gastroenterology & Endoscopy News
Professor of Medicine
Chair of the Digestive Disease & Surgery Institute
Cleveland Clinic, Cleveland
Chair of the Digestive Disease & Surgery Institute
Cleveland Clinic, Cleveland
In this month’s The Regueiro Report, I highlight two studies on medications to treat inflammatory bowel disease.
The first study in this month’s report, a meta-analysis, discusses switching to subcutaneous infliximab or vedolizumab